VZV ORF9, Varicella Zoster Virus Antigen, Recombinant

Full Name

Abbreviated Name-1

VZV ORF9;

Documents
Figures
Reference
Wang GQ, et al. Generation of a reporter cell line for detection of infectious varicella-zoster virus and its application to antiviral studies. Antimicrob. Agents Chemother. Sep 2006; 50(9): 3142-3145. Sato B, et al. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J. Virol. May 2003; 77(10): 5607-5620. Spengler M, et al. Interactions among structural proteins of varicella zoster virus. Arch. Virol. Suppl. 2001; (17): 71-79.

Description

Varicella Zoster Virus (VZV) ORF9 is an E. coli-derived recombinant. GenScript Varicella Zoster Virus (VZV) ORF9 contains the VZV ORF9 immunodominant regions.

Source

E. coli

Purity

Protein is >95% pure as determined by 10% PAGE (coomassie staining).

Storage

Protein is shipped at ambient temperature. Upon arrival, store at -20°C.

Concentration

1 mg/ml in 25 mM Tris-HCl, 1 mM EDTA, 50% glycerol.

Stability

Five years frozen. One month in solution at room temperature.

Specificity

Immunoreactive with sera of VZV-infected individuals.

Applications

Antigen in ELISA and Western blots, excellent antigen for detection of VZV with minimal specificity problems.

Note

;


1	Custom Recombinant Protein Services: Guaranteed E. coli Expression Package-3 mg purified soluble protein from $2,200 .
2	Bacterial Expression System: GenScript has developed BacPower^TM technologies to tackle hard-to-express and hard-to-dissolve proteins.
3	Yeast Expression System: GenScript's proprietary YeastHIGH^TM technology combines the advantages of the bacterial and eukaryotic expression systems.
4	Baculovirus/Insect Cell Expression System: GenScript developed BacuVance^TM platform for the secretion of recombinant proteins from baculovirus-infected insect cells.
5	Mammalian Cell Expression System: The proprietary 293 and CHO suspension system platform promotes fast production and delivery of recombinant proteins and monoclonal antibodies up to grams level.